Patel Trisha, Ilardi Dawn, Kochilas Lazaros
Emory University School of Medicine, 1405 Clifton Road, Atlanta, GA 30322, USA; Children's Healthcare of Atlanta, 1400 Tullie Road, Atlanta, GA 30329, USA.
Emory University School of Medicine, 1405 Clifton Road, Atlanta, GA 30322, USA; Children's Healthcare of Atlanta, 1400 Tullie Road, Atlanta, GA 30329, USA.
Clin Perinatol. 2023 Mar;50(1):53-66. doi: 10.1016/j.clp.2022.10.002.
Even before birth, children with congenital heart disease (CHD) are at risk for neurodevelopmental concerns, with additional insults occurring as part of their treatment course and from subsequent exposures to socioeconomic stressors. With multiple affected neurodevelopmental domains, individuals with CHD face lifelong cognitive, academic, psychological, and quality-of-life difficulties. Early and repeated neurodevelopmental evaluation is key to receiving appropriate services. However, obstacles at the level of the environment, provider, patient, and family can make the completion of these evaluations difficult. Future neurodevelopmental endeavors should aim to evaluate CHD-specific programs, their effectiveness, and barriers to access.
甚至在出生前,患有先天性心脏病(CHD)的儿童就面临神经发育问题的风险,在其治疗过程中以及随后暴露于社会经济压力源时还会受到额外的损害。由于多个神经发育领域受到影响,患有CHD的个体面临着终身的认知、学业、心理和生活质量方面的困难。早期和反复的神经发育评估是获得适当服务的关键。然而,环境、提供者、患者和家庭层面的障碍会使这些评估难以完成。未来的神经发育研究应旨在评估特定于CHD的项目、其有效性以及获得服务的障碍。